Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction.
about
Cellular and molecular mechanisms of fibrosisTreatment of allergic asthma: modulation of Th2 cells and their responsesUnlipidated outer membrane protein Omp16 (U-Omp16) from Brucella spp. as nasal adjuvant induces a Th1 immune response and modulates the Th2 allergic response to cow's milk proteinsOsteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsetsRole of infections in the induction and development of asthma: genetic and inflammatory driversMechanisms of peripheral tolerance to allergensAltered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthmaTolerization of a type I allergic immune response through transplantation of genetically modified hematopoietic stem cells.A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation.A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice.Suppression of allergic airway inflammation and IgE responses by a class I restricted allergen peptide vaccine.Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk.Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.Innate immunity of the sinonasal cavity and its role in chronic rhinosinusitis.Airway house dust extract exposures modify allergen-induced airway hypersensitivity responses by TLR4-dependent and independent pathways.Functions of T cells in asthma: more than just T(H)2 cells.Control and regulation of peripheral tolerance in allergic inflammatory disease: therapeutic consequencesCpG-containing immunostimulatory DNA sequences elicit TNF-alpha-dependent toxicity in rodents but not in humans.Signals for the execution of Th2 effector function.Guilt by intimate association: what makes an allergen an allergen?Immunoregulation of GVHD by triggering the innate immune system with CpG.Nucleotide oligomerization domain 1 ligation suppressed murine allergen-specific T-cell proliferation and airway hyperresponsiveness.Investigational drugs for the treatment of allergic rhinitis.Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.Type 2 cytokines: mechanisms and therapeutic strategies.Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.Is The Allergen Really Needed in Allergy Immunotherapy?Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study.Immunostimulatory oligodeoxynucleotide containing TTTCGTTT motif from Lactobacillus rhamnosus GG DNA potentially suppresses OVA-specific IgE production in mice.Asthma phenotypes in adults and clinical implications.
P2860
Q24648892-1BB908FB-1374-4CE2-8623-664DA7E97E57Q27011823-3ED4AF6C-3DA2-4323-9948-E587BAA352B9Q27311087-F3207AA4-948F-4C49-9302-114BE28EC812Q28298064-AFAB2DC5-0B44-4931-9CCD-85581A4C9B97Q28389983-2E84A0AA-B846-4469-A194-CB48C34910E8Q29027397-FC45BB6D-A6A9-4FE8-91AC-59A900ED2C9AQ33655907-1582468E-C2D3-446A-B038-7C60A07B0551Q34361879-6C1553DD-59F0-4895-8248-525E42829CF0Q35853440-FD7BFB3F-6963-427F-A573-24727F91BFBFQ35889245-79B808E1-7859-42ED-816A-533B8E7008EFQ36023560-3FDB4F90-A237-4927-A891-8436447E4382Q36064566-FAB7A0F1-F5BA-43A0-864E-7C8BF82D3E7EQ36229564-9152EA1D-01FC-4DAE-9A0C-56F04D53E191Q36526351-A812AD2B-4E4B-4307-8AB5-E4D0FEEC3809Q36745067-391812A8-4FDE-4271-B318-029F88FD56C0Q36983216-C84AC5EE-12D4-43EE-86FF-7689EB21AB55Q37253949-8C517345-8A01-4C0E-BEBE-9A35645D1A81Q37273165-4AB56745-F12D-4F8E-9501-508B169C5551Q37328524-22A806DF-B518-42B5-A73E-68CC42F42ACDQ37399731-060294D7-A8FA-4F9E-A2FF-6A3393A151C0Q37728533-B66B07F2-FE20-49CE-8931-2F3BA6DD25B4Q37810081-864ACAB7-6AA2-476D-88A0-046A64338C5AQ37845464-B4F2A72D-EBA6-4BD8-BA39-CE9A1C891AE4Q38202695-CD40D13B-814A-442F-A78F-ED5B7FB64D60Q38217708-ED90BE44-C08D-40E8-A830-91804FD3DA95Q38424752-08E3AD5F-01B0-4779-8AB8-E3211428319FQ41895016-A86D8A82-1557-42B5-90F8-56FA3319CE8BQ42730811-D1539A42-1BE2-4B79-BB67-4E6A70EC9A53Q48650567-15377802-FFEC-45DC-A197-04B65E099FCEQ51791575-E68A752F-49FE-456E-8EC5-2073EAAF34EFQ53067800-6FBE7982-42F1-4265-95F9-89CC1C784445
P2860
Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Immunostimulatory oligonucleot ...... E-mediated cytokine induction.
@ast
Immunostimulatory oligonucleot ...... E-mediated cytokine induction.
@en
type
label
Immunostimulatory oligonucleot ...... E-mediated cytokine induction.
@ast
Immunostimulatory oligonucleot ...... E-mediated cytokine induction.
@en
prefLabel
Immunostimulatory oligonucleot ...... E-mediated cytokine induction.
@ast
Immunostimulatory oligonucleot ...... E-mediated cytokine induction.
@en
P2093
P2860
P356
P1476
Immunostimulatory oligonucleot ...... E-mediated cytokine induction.
@en
P2093
Bonnie Chang
Edith M Hessel
Jennifer O Lizcano
Marsha Wills-Karp
Nancy Herman
Robert L Coffman
Sariah A Kell
P2860
P304
P356
10.1084/JEM.20050631
P407
P577
2005-11-28T00:00:00Z